Ley K, Baker J B, Cybulsky M I, Gimbrone M A, Luscinskas F W
Freie Universität Berlin, Department of Physiology, Germany.
J Immunol. 1993 Dec 1;151(11):6347-57.
Injection (i.v.) of the granulocyte chemoattractant/activator IL-8 has been shown to reduce neutrophil recruitment into dermal inflammatory sites in vivo. To further investigate the mechanism of this phenomenon, we examined the effect of i.v. [Ser-IL-8]72 (12-20 micrograms/kg) on leukocyte rolling and chemoattractant-induced emigration in mesenteric venules of New Zealand White rabbits and on expression of L-selectin (mAb LAM1-3) and CD18 (mAb 60.3) on circulating rabbit granulocytes. Within 1 min of IL-8 i.v., granulocytes virtually disappeared from carotid blood samples for approximately 5 min. Concomitantly, the flux of rolling leukocytes in mesenteric venules fell from 83 +/- 21 to 2 +/- 1 leukocytes/min. Both rolling leukocyte flux and systemic granulocyte count returned to or exceeded control values within less than 30 min. The chemoattractant/activator FMLP (0.15 microgram/kg i.v.) produced similar results. A second i.v. injection of IL-8 or FMLP, 90 min after the first challenge, had equipotent effects. Local extravascular application of IL-8 via micropipette close to a venule induced adhesion and emigration of 63 +/- 21 leukocytes per site before, but only 26 +/- 9 leukocytes per site 50 to 75 min after i.v. IL-8, when systemic granulocyte count and rolling leukocyte flux had reached or exceeded control values. This was not due to agonist-specific desensitization, because a similar reduction of leukocyte emigration was seen after FMLP i.v. Rabbit granulocytes circulating in vivo uniformly expressed near-control levels of L-selectin at all times between 3 and 360 min after IL-8 i.v. CD18 expression transiently increased after IL-8 i.v. and returned to base line by 90 min. These findings show that IL-8 i.v. reduces granulocyte recruitment to inflammatory sites by inhibiting function(s) necessary for transmigration that are independent of L-selectin and subsequent to rolling.
静脉注射粒细胞趋化因子/激活剂白细胞介素-8(IL-8)已被证明可在体内减少中性粒细胞向皮肤炎症部位的募集。为了进一步研究这一现象的机制,我们检测了静脉注射[Ser-IL-8]72(12 - 20微克/千克)对新西兰白兔肠系膜小静脉中白细胞滚动和趋化因子诱导的移出的影响,以及对循环兔粒细胞上L-选择素(单克隆抗体LAM1-3)和CD18(单克隆抗体60.3)表达的影响。静脉注射IL-8后1分钟内,粒细胞在大约5分钟内几乎从颈动脉血样本中消失。与此同时,肠系膜小静脉中滚动白细胞的通量从83±21降至2±1个白细胞/分钟。滚动白细胞通量和全身粒细胞计数在不到30分钟内恢复到或超过对照值。趋化因子/激活剂甲酰甲硫氨酸-亮氨酸-苯丙氨酸(FMLP,0.15微克/千克静脉注射)产生了类似的结果。在首次注射90分钟后第二次静脉注射IL-8或FMLP,具有同等效力。通过微量移液器在靠近小静脉处局部血管外应用IL-8,在静脉注射IL-8前每个部位诱导63±21个白细胞黏附和移出,但在静脉注射IL-8后50至75分钟,当全身粒细胞计数和滚动白细胞通量达到或超过对照值时,每个部位仅诱导26±9个白细胞黏附和移出。这并非由于激动剂特异性脱敏,因为静脉注射FMLP后也观察到白细胞移出有类似减少情况。静脉注射IL-8后3至360分钟之间的所有时间,体内循环的兔粒细胞始终均匀表达接近对照水平的L-选择素。静脉注射IL-8后CD18表达短暂增加,并在90分钟时恢复到基线水平。这些发现表明,静脉注射IL-8通过抑制与L-选择素无关且发生在滚动之后的迁移所需功能,减少粒细胞向炎症部位的募集。